Publications by authors named "E Scarpelli"
Unveiling the advantages of laparoscopic myomectomy: A comprehensive systematic review and meta-analysis of outcomes and complications compared with traditional open surgery.
Eur J Obstet Gynecol Reprod Biol
December 2024
Article Synopsis
- The study compares laparoscopic myomectomy (LM) and open myomectomy (OM) by analyzing postoperative complications, blood loss, operative time, and length of hospital stay using the Clavien-Dindo classification.
- LM showed significantly lower rates of overall postoperative complications and mean blood loss compared to OM, with an associated statistically significant shorter hospital stay.
- Additionally, while operative times were similar, the findings indicate a clear advantage for LM in terms of patient recovery and safety.
Article Synopsis
- Endometriosis is a non-cancerous condition affecting women that may be linked to an increased risk of ovarian cancer, specifically certain types like endometrioid and clear cell subtypes.
- Atypical endometriosis (AE) shows unusual microscopic features that complicate its diagnosis, necessitating thorough histological evaluation to identify its distinct architectural and cytologic forms.
- Long-term studies indicate low rates of recurrence and malignancy in AE patients, but further research and interdisciplinary collaboration are essential to grasp the condition's cancer risk and improve diagnostic methods.
Ovarian cancer (OC) remains a significant health challenge globally, with high mortality rates despite advancements in treatment. Emerging research suggests a potential link between OC development and genital dysbiosis, implicating alterations in the microbiome composition as a contributing factor. To investigate this correlation, a meta-analysis was conducted following PRISMA and MOOSE guidelines, involving eight studies encompassing 3504 patients.
View Article and Find Full Text PDFMinimally Invasive Surgery (MIS) represents a safe and feasible option for the surgical treatment of gynecologic malignancies, offering benefits, including reduced blood loss, lower complications, and faster recovery, without compromising oncological outcomes in selected patients. MIS is widely accepted in early-stage gynecologic malignancies, including endometrial cancer, cervical tumors measuring 2 cm or less, and early-stage ovarian cancer, considering the risk of surgical spillage. Despite its advantages, MIS does not rule out the possibility of adverse events such as postoperative infections.
View Article and Find Full Text PDF